RafleRifaximin
Rafle is marketed by Alembic. 3 packs on NPPA's price list for July 2026, containing Rifaximin.
- Packs listed
- 3
- Lowest MRP
- ₹232.03
- Per unit
- ₹23.20 to ₹54.22
- Price-controlled packs
- 0 of 3
- Dosage forms
- 2
Packs and prices
- ₹232.03Rafle 200 mg Tablet 10Rifaximin Tablet 200 mg · ₹23.20 per tablet
- ₹542.16Rafle 550 mg Tablet 10Rifaximin Tablet 550 mg · ₹54.22 per tablet
- ₹462.09Rafle 400 mg Tablet ER 10Rifaximin Tablet ER 400 mg · ₹46.21 per tablet
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Rifaximin Tablet 200 mg
- ₹9.64/tabletColigut · 10 tabletUniventis Medicare · MRP ₹96.35
- ₹12.00/tabletRifgem · 10 tabletHetero Healthcare · MRP ₹120.00
- ₹12.20/tabletRifeasy · 10 tabletMSN Laboratories · MRP ₹122.00
- ₹13.39/tabletRidol RX · 10 tabletGufic Bioscience · MRP ₹133.92
- ₹14.29/tabletRixmin · 10 tabletCipla · MRP ₹142.86
- ₹15.00/tabletGutwin · 10 tabletWin-Medicare · MRP ₹150.00
- ₹15.00/tabletRifabiz · 10 tabletAlniche Life Sciences · MRP ₹150.00
- ₹16.40/tabletMenarif · 10 tabletMenarini India · MRP ₹164.00
50 other brands of this composition on the price list; the 8 lowest per tablet are shown. All Rifaximin packs
Rifaximin Tablet 550 mg
- ₹18.52/tabletRimigut · 10 tabletElder Labs · MRP ₹185.16
- ₹19.50/tabletRifaxitab · 10 tabletAlkem Laboratories · MRP ₹195.00
- ₹24.10/tabletColigut · 10 tabletUniventis Medicare · MRP ₹241.00
- ₹31.50/tabletGutwin · 10 tabletWin-Medicare · MRP ₹315.00
- ₹31.75/tabletRifeasy · 10 tabletMSN Laboratories · MRP ₹317.46
- ₹33.00/tabletRifabet · 10 tabletFDC · MRP ₹330.00
- ₹35.78/tabletRifaset · 10 tabletMacleods Pharmaceuticals · MRP ₹357.84
- ₹36.50/tabletMenarif · 10 tabletMenarini India · MRP ₹365.00
52 other brands of this composition on the price list; the 8 lowest per tablet are shown. All Rifaximin packs
The company
Alembic has 617 packs on the price list, and CDSCO has named it as the manufacturer of 4 failed batches since Jul 2015. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.